Scientists test novel drug duo in fight against Tough-to-Treat sarcomas
NCT ID NCT05180695
Summary
This study is testing a new combination of two drugs, HDM201 and pazopanib, for people with advanced soft tissue sarcoma that has spread and stopped responding to standard chemotherapy. The first part aims to find the safest dose of the combination. The second part will gather early information on whether this drug combo can help control the cancer and prevent it from getting worse for at least six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOFT-TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Bérard
Lyon, 69373, France
-
Institut Bergonié
Bordeaux, 33800, France
-
Institut Claudius Regaud
Toulouse, 31059, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut Paoli-Calmettes
Marseille, 13273, France
Conditions
Explore the condition pages connected to this study.